These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10565496)

  • 1. Neuropeptide abnormalities in patients with early Alzheimer disease.
    Davis KL; Mohs RC; Marin DB; Purohit DP; Perl DP; Lantz M; Austin G; Haroutunian V
    Arch Gen Psychiatry; 1999 Nov; 56(11):981-7. PubMed ID: 10565496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
    Davis KL; Mohs RC; Marin D; Purohit DP; Perl DP; Lantz M; Austin G; Haroutunian V
    JAMA; 1999 Apr; 281(15):1401-6. PubMed ID: 10217056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine.
    Nemeroff CB
    Arch Gen Psychiatry; 1999 Nov; 56(11):991-2. PubMed ID: 10565497
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.
    Haroutunian V; Purohit DP; Perl DP; Marin D; Khan K; Lantz M; Davis KL; Mohs RC
    Arch Neurol; 1999 Jun; 56(6):713-8. PubMed ID: 10369312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
    Haroutunian V; Perl DP; Purohit DP; Marin D; Khan K; Lantz M; Davis KL; Mohs RC
    Arch Neurol; 1998 Sep; 55(9):1185-91. PubMed ID: 9740112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
    Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
    Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
    Whitford C; Candy J; Edwardson J; Perry R
    J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.
    Bierer LM; Haroutunian V; Gabriel S; Knott PJ; Carlin LS; Purohit DP; Perl DP; Schmeidler J; Kanof P; Davis KL
    J Neurochem; 1995 Feb; 64(2):749-60. PubMed ID: 7830069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment represents early-stage Alzheimer disease.
    Morris JC; Storandt M; Miller JP; McKeel DW; Price JL; Rubin EH; Berg L
    Arch Neurol; 2001 Mar; 58(3):397-405. PubMed ID: 11255443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
    Minthon L; Edvinsson L; Gustafson L
    Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
    Gabriel SM; Davidson M; Haroutunian V; Powchik P; Bierer LM; Purohit DP; Perl DP; Davis KL
    Biol Psychiatry; 1996 Jan; 39(2):82-91. PubMed ID: 8717605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of corticotropin-releasing factor-immunoreactive nervous tissue and colocalization with neuropeptide Y-like substance in the optic lobe and peduncle complex of the octopus (Octopus vulgaris).
    Suzuki H; Muraoka T; Yamamoto T
    Cell Tissue Res; 2003 Jul; 313(1):129-38. PubMed ID: 12838406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal fluid CRF reduction in Alzheimer's disease.
    Mouradian MM; Farah JM; Mohr E; Fabbrini G; O'Donohue TL; Chase TN
    Neuropeptides; 1986; 8(4):393-400. PubMed ID: 3493444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
    Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
    Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.
    Bierer LM; Hof PR; Purohit DP; Carlin L; Schmeidler J; Davis KL; Perl DP
    Arch Neurol; 1995 Jan; 52(1):81-8. PubMed ID: 7826280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics.
    Frederiksen SO; Ekman R; Gottfries CG; Widerlöv E; Jonsson S
    Acta Psychiatr Scand; 1991 Apr; 83(4):273-7. PubMed ID: 1709331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.
    Bissette G; Reynolds GP; Kilts CD; Widerlöv E; Nemeroff CB
    JAMA; 1985 Dec; 254(21):3067-9. PubMed ID: 3877182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.